NICE rejects Roche’s Polivy combination in advanced lymphomaEngland’s NHS should not fund Roche’s Polivy (polatuzumab vedotin) in combination with rituximab and bendamustine for adults with Share XNICE rejects Roche’s Polivy combination in advanced lymphomahttps://pharmaphorum.com/news/nice-rejects-roches-polivy/
First UK patients get Novartis’ Luxturna gene therapy for blindnessThe first NHS patients have started treatment with Novartis’ Luxturna, a gene therapy for a sight-robbing inherited disease, Share XFirst UK patients get Novartis’ Luxturna gene therapy for blindnesshttps://pharmaphorum.com/news/first-uk-patients-get-novartis-luxturna-gene-therapy-for-blindness/
NICE backs Axonics’ rechargeable device for overactive bladderA device to treat urinary incontinence made by US biotech Axonics has been recommended for NHS use by Share XNICE backs Axonics’ rechargeable device for overactive bladderhttps://pharmaphorum.com/news/nice-backs-axonics-rechargeable-device-for-overactive-bladder/
NICE rejects MSD/Pfizer’s combination in untreated kidney cancerNICE said “no” to NHS funding for a combination of MSD’s Keytruda (pembrolizumab) immunotherapy and Pfizer’s Inlyta (axitinib) Share XNICE rejects MSD/Pfizer’s combination in untreated kidney cancerhttps://pharmaphorum.com/news/nice-rejects-msd-pfizers-combination-in-untreated-kidney-cancer/
Novartis plots cardio trial in UK as London HQ opensNovartis has announced the beginnings of a major cardiovascular outcomes trial in the UK, as it opened a Share XNovartis plots cardio trial in UK as London HQ openshttps://pharmaphorum.com/news/novartis-plots-cardio-trial-in-uk-as-london-hq-opens/
After rejection, NICE agrees to look again at migraine drug AimovigThe UK’s medicines cost-effectiveness agency NICE has agreed to look again at its decision to turn down NHS Share XAfter rejection, NICE agrees to look again at migraine drug Aimovighttps://pharmaphorum.com/news/nice-migraine-aimovig/
Child with rare disease takes NICE to court over access to life-changing therapyNICE’s decision-making process will come under legal scrutiny in court this week, after a child and her family Share XChild with rare disease takes NICE to court over access to life-changing therapyhttps://pharmaphorum.com/news/child-with-rare-disease-takes-nice-to-court-over-access-to-life-changing-therapy/
Digital interventions could help behaviour change, says NICEThe UK’s health watchdog has said health professionals can consider digital and mobile interventions as a supplement to Share XDigital interventions could help behaviour change, says NICEhttps://pharmaphorum.com/news/digital-interventions-could-help-behaviour-change-says-nice/
NHS patients denied new lung cancer drug after another NICE deadlockCertain untreated lung cancer patients on England’s NHS will have to make do with older drugs after NICE Share XNHS patients denied new lung cancer drug after another NICE deadlockhttps://pharmaphorum.com/news/nice-deadlock/
